Results: Relaxation to peroxynitrite was concentration-dependent and endothelium-independent. The abilities of the SERCA blocker thapsigargin and the PMCA inhibitor carboxyeosin to block this relaxation were altered during fat feeding and plaque progression. SERCA levels were progressively reduced, while PMCA expression was upregulated. In ApoE À/À VSM cells, increases in cytosolic Ca 2þ [Ca 2þ ] c in response to SERCA blockade were reduced, while SERCA-independent Ca 2þ clearance was faster compared to control. Conclusion: As atherosclerosis develops in the ApoE À/À mouse, expression and function of Ca 2þ handling proteins are altered. Up-regulation of Ca 2þ removal via PMCA may offer a potential compensatory mechanism to help normalise the dysfunctional relaxation observed during disease progression.
Introduction
Increased oxidant stress is implicated in the progression of several diseases affecting the vasculature, including hypertension, diabetes and atherosclerosis [1e4] . In vascular smooth muscle (VSM), reactive oxygen (ROS) and nitrogen species (RNS) can alter core functions [5] , including migration, cell growth, vascular reactivity and inflammatory processes [6e8]; all critical factors in the development and progression of atherosclerosis and cardiovascular disease. One such RNS, peroxynitrite (ONOO À ), is the reaction product of nitric oxide (NO) and superoxide (O 2 . ) and has direct and indirect effects on the relaxation of blood vessels [9e12] . However, the precise mechanism by which ONOO À induces relaxation remains unclear. Ca 2þ is the fundamental second messenger controlling VSM contraction and relaxation, and can enter the cytoplasm via membrane depolarisation, non-selective cation channels, store operated Ca 2þ entry (SOCE) or from the sarcoplasmic reticulum (SR) [13] . Ca 2þ clearance occurs either via re-uptake into the SR via sarco/endoplasmic reticulum Ca 2þ ATPase (SERCA) pumps [14] , which utilise energy from ATP hydrolysis to maintain a 10000-fold Ca 2þ gradient between the SR lumen and cell cytoplasm, or extrusion into the extracellular space via the plasma membrane Ca 2þ ATPase (PMCA) [15] or sodium Ca 2þ exchanger (NCX) [16] . In healthy vessels, ONOO À has been shown to induce relaxation of rat aorta following constriction to phenylephrine [12] . This relaxation was not reduced by inhibitors of nitric oxide synthase or endothelial denudation, and was thought to occur via elevation of cGMP levels, membrane hyperpolarisation and direct activation of myosin phosphatase activity in the smooth muscle. A further potential mechanism for ONOO À -induced vascular relaxation is via increased uptake of Ca 2þ into the internal SR store via SERCA or extrusion across the plasma membrane. Lower levels of ONOO À (10e50 mM) have been shown, in purified cardiac fractions and aorta homogenates, to increase the activity of SERCA via reversible S-glutathiolation [9] . Conversely, higher ONOO À concentrations (>100 mM) were associated with tyrosine nitration and SERCA inhibition. ONOO À has also been determined to contribute to atherogenesis [17] , and chronically elevated levels of RNS in atherosclerotic rabbit arteries impair SERCA activity by irreversible oxidation of relevant cysteine thiols [9] . Oxidative stress has also been shown to target the plasma membrane pump PMCA in disease states; altering Ca 2þ extrusion in platelets [18] and neuronal tissue [19] homoeostasis under oxidative stress [23] . Therefore, significant evidence exists for the interplay of reactive species and Ca 2þ signalling mechanisms [24] . In addition, defects in smooth muscle Ca 2þ handling has been shown to affect responses to vasodilators [25] . In this study, we have utilised pharmacological Ca 2þ pump inhibitors to examine the effect of up to 4 months high fat feeding of atherosclerosis-prone ApoE À/À mice on ONOO À -mediated relaxation. Mice on a high fat diet are reported to have approximately 5% lesion coverage of the aorta [39] but, even prior to the development of lesions, changes in smooth muscle function are apparent [26] . This indicates the importance of circulating factors and perhaps the influence of other cell types present in the lesion on smooth muscle function. 
Histological analysis
Cleaned thoracic aortae were fixed in neutral-buffered formalin, embedded in paraffin and 4 mm sections cut on a rotary microtome.
Morphological analysis was performed on haematoxylin and eosin stained sections. Nitrotyrosine (Millipore) and a-actin (Abcam)
were detected using rabbit primary antibodies (diluted 1 in 100) and visualised using biotin labelled secondary antibodystreptavidin-HRP complexes and DAB (3,3 0 diaminobenzidine) chromogenic substrate (Vector Laboratories). Images were analysed using ImmunoRatio analysis software (IBT, University of Tampere), which calculates the percentage of DAB staining over total nuclear area.
Small vessel wire myography
Descending thoracic aorta was systematically divided into rings of 2 mm, and endothelium was removed. Rings were mounted on a small vessel wire myograph (Danish Myotech), placed under a resting tension of 1 g and allowed to equilibrate. Reproducible responses were obtained to 40 mM KCl and 30 nM 9,11-Dideoxy9a,11a-methanoepoxy prostaglandin F 2a (U46619, Tocris) and endothelial function was assessed by the addition of 10 mM acetylcholine before commencing experiments. Rings were precontracted to U46619 (30 nM) were added 30 min prior to ONOO À .
Protein expression/immunoblotting
Denuded aortae were pulverised in liquid nitrogen and incubated in lysis buffer (50 mM TriseHCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.25% (w/v) Na-deoxycholate, 1% (v/v) TX-100, 1Â protease inhibitor cocktail (Roche)) for 30 min at 4 C. Lysates were spun to remove debris, and protein concentrations determined using Coomassie Plus Protein Assay Reagent (Perbio, USA). Denatured samples were subjected to electrophoresis (NuPAGE, 3e8% triseacetate gels (Invitrogen)) and western blotting. SERCA was detected using rabbit polyclonal anti-SERCA2b (a kind gift from Prof. F Wuytack, Leuven). SERCA2b was identified as a dimer, with a fainter monomer band detected at 110 kDa. Protein abundance was quantified from a range of protein loads using Quantity One software (BioRad). PMCA (Affinity Bioreagents) was detected and quantified similarly. Expression was normalised to GAPDH (Cell Signaling Technology). ); and EGTA, 1. Fluorescence was quantified using a microfluorimeter, which consisted of an inverted microscope (Olympus IX81) and a photomultiplier tube with a bi-alkali photocathode. Fluo-3 was excited at 488 nm (bandpass 9 nm) from a PTI Delta Scan (Photon Technology International Inc., London, UK) through the epi-illumination port of the microscope. Excitation light was passed through a field stop diaphragm to reduce background fluorescence and reflected off a 505 nm long-pass dichroic mirror. Emitted light was guided through a 535 nm barrier filter (bandpass 35 nm) to a photomultiplier in photon counting mode. Caffeine (10 mM) was applied by hydrostatic pressure ejection using a pneumatic pump (PicoPump PV 830, World Precision Instruments).
TG (1 mM) was perfused into the solution bathing the cells.
Statistical analysis
Myography data was analysed via Graphpad Prism software and significance determined using 2-way ANOVA. EC 50 were determined using non-linear fit curve analysis of individual data sets followed by ANOVA. 
Results

Protein nitrosylation is increased in atherosclerotic ApoE
À/À mouse aortae
Nitrotyrosine expression was higher in ApoE À/À thoracic aorta in comparison to C57/BL-6 and particularly marked in medial and adventitial areas around atherosclerotic plaques ( Fig. 1a and b) . Some diffuse staining also was found within the plaque. There was significantly more nitrotyrosine detected (Fig. 1b) Spleen size in atherosclerotic mice was also significantly and progressively increased with time spent on high fat diet (0.27 AE 0.03, 0.40 AE 0.04* and 0.52 AE 0.07** % of total body weight for C57/BL-6, 2 month and 4 month high fat fed ApoE À/À respectively, *p < 0.05 and **p < 0.01 vs. C57/BL-6); an indicator of progressive inflammatory responses in these mice which is known to be correlated to peroxynitrite bioavailability. Smooth muscle a-actin staining revealed similar numbers of smooth muscle cells in C57/BL-6 and ApoE À/À aortic sections ( Fig. 1 c, d and e, 49.83 AE 10.71% vs.
58.14 AE 5.03%), with smooth muscle staining also being observed in the fibrous cap of plaques in ApoE À/À aortae (Fig. 1d) . Haematoxylin and eosin staining revealed typical plaque morphology in ApoE À/À aortic cross-sections from mice which have been fed a high fat diet for 4 months (Fig. 1f) .
Mouse thoracic aorta relaxes to ONOO
À in a dose-dependent manner Endothelium denuded aortic rings relaxed to ONOO À in a concentration dependent manner (Fig. 2a) . In 2 month ApoE À/À mice sensitivity to ONOO À was increased (Fig. 2b, (Fig. 3a) was significantly downregulated in aortic smooth muscle from ApoE À/À (45% reduction, *p < 0.05 vs. C57/BL-6 after 2 months fat feeding and 75%, ***p < 0.001 vs. C57/BL-6 after 4 months). In contrast, expression of PMCA (Fig. 3b ) was significantly upregulated (by 45%, *p < 0.05 vs. C57/BL-6 following 2 months high fat feeding and by **137%, p < 0.01 vs. C57/BL-6 following 4 months). We found no significant changes in NCX expression at 2 months and a significant reduction at 4 months (data not shown).
Efficacy of Ca 2þ pump inhibitors is temporally altered as atherosclerosis progresses
As ONOO À is known to activate SERCA [9] , the expression of which is progressively reduced in atherosclerotic VSM (Fig. 3a) , we next evaluated the function of SERCA using the irreversible SERCA inhibitor thapsigargin (TG). Contraction of endothelium denuded aortic rings to U46619 did not differ among groups or between controls and TG pre-treated tissues. TG (3 mM) was found to inhibit ONOO À -induced relaxation in control and atherosclerotic aorta [ Fig. 4aec] (Fig. 5a ). Caffeine responses were similar across control and atherosclerotic groups ( Fig. 5b and e experiments, the increased expression of PMCA in atherosclerotic VSMs (Fig. 3c) , may be responsible for the more rapid sarcolemmal Ca 2þ extrusion observed in ApoE À/À cells in Fig. 5c and f.
Discussion
In previous investigations in canine coronary and cerebral arteries and rabbit and rat aortae [12,30e33] , the pro-oxidant ONOO À relaxed pre-contracted C57/BL-6 and ApoE À/À mouse aorta. However, we additionally report for the first time that this vasodilator response (Fig. 2b) , and the expression and function of VSM SERCA and PMCA (Figs. 3 and 4) , are altered with time on high fat diet and reveal modifications and compensatory mechanisms of Ca 2þ handling in the disease state (Fig. 5) . Facilitation of cellular Ca 2þ removal requires a combination of SR Ca 2þ uptake via SERCA and plasma membrane extrusion [34] via PMCA and NCX, although the extent of the involvement of the latter protein is controversial in aortic smooth muscle [20e22,35] . Importantly though, the majority of Ca 2þ clearance in mouse aortic VSM (60e70%) has been attributed to the combined function of PMCA and SERCA and not NCX and SERCA [36] . We therefore focussed this study on the impact of SERCA and PMCA. The changes we observed in relaxation to ONOO À over time in vessels from fat fed animals will be influenced not only by our observed changes in SERCA function and SOCE, but also by the compensatory changes we have identified in the expression and function of PMCA. We suggest the altered balance and influence of these processes accounts for the altered sensitivity to ONOO À observed in this study.
Surprisingly, ONOO À -induced relaxation was enhanced in ApoE À/À mice which had been high fat fed for 2 months while, after 4 months on diet, this enhancement was lost (Fig. 2b) . Improved smooth muscle cell function in ApoE deficient mice has not been reported previously, however a recent study by Beleznai et al. [40] did reveal increased endothelial cell function and sensitivity to dilation in the mesenteric arteries of ApoE À/À of 9e14 weeks of age.
This increased sensitivity was reduced in older ApoE À/À [40] , which correlates with our findings presented here on aortic smooth muscle. Paradoxically, although we observed greater relaxation of aortae from 2 month fat fed ApoE À/À mice, SERCA expression was significantly reduced in comparison to controls. We would suggest that a compensatory upregulation of calcium extrusion occurs in the smooth muscle of ApoE À/À mice, which allows for augmented relaxation at the earlier 2 month time-point but is "over-ridden" by smooth muscle dysfunction as age and time on high fat diet increases. Our data suggests that PMCA is likely to be responsible for the increased calcium extrusion and enhanced relaxation to ONOO À at 2 months high fat diet since expression was increased (Fig. 3b ) and the PMCA inhibitor carboxyeosin normalised the enhanced relaxation to ONOO À (Fig. 4e) .
Release of Ca 2þ from the SR will also activate SOCE, which is upregulated in ApoE knockout mice [26] . We have confirmed this finding in our single cell experiments through the addition of the SERCA blocker (and, consequently, SOCC activator) TG in extracellular Ca 2þ -containing and Ca 2þ -free/EGTA conditions (Fig. 5 ).
We also report here for the first time that the TG-induced increase in [Ca 2þ ]c (in extracellular Ca 2þ -free conditions) is reduced in aortic smooth muscle from ApoE À/À (Fig. 5e ) and this is in line with our finding that SERCA protein expression is reduced in these samples (Fig. 3a) . SERCA plays an important role in ONOO À -induced relaxation, since pre-treatment with TG caused significant reduction in relaxation in aortae from C57/BL-6 and ApoE À/À mice (Fig. 4aec) entry via SOCCs potentially precludes relaxation following incubation with TG at this later time point. Interestingly, a recent paper by Barriga et al. [41] reported that SERCA2 protein levels are reduced in cultured atrial myocytes by the addition of LDL. Data from our laboratory has indicated there is no significant decrease in SERCA2b expression between agematched chow-fed C57/BL-6 and ApoE À/À aortae (data not shown). Other studies have shown raised LDL levels with time spent on high fat diet [42e44], with approximately a two-fold increase in comparison to chow-fed animals. Since we have shown reduced SERCA expression following 2 and 4 months high fat feeding, it is probable that in addition to the impact of atherosclerosis, increased LDL levels may play a role in altered SERCA expression and function.
No other investigators to date have specifically investigated the temporal relationship between atherosclerotic development, high fat feeding and the relationship between smooth muscle cell SERCA and PMCA, although other studies have observed a compensatory relationship between the two in other cell types. Over-expression of PMCA has been shown to lead to down-regulation of the SERCA pump in rat aortic endothelial cells by Liu et al. [37] and work by Wang et al. [38] indicates that PMCA functions cooperatively with SERCA and NCX in rabbit aortic endothelium. We therefore believe that this study represents an important step forward in the understanding of the temporal and compensatory alterations observed in VSM function between healthy and hypercholesterolaemic ApoE À/À mice.
Conclusion
For the first time we have demonstrated time-dependent changes in the expression and activity of Ca 2þ regulatory mechanisms in VSM during progressive high fat feeding in atherosclerosis-prone mice. Compensatory changes, comprising a rise in PMCA expression, coupled with a fall in SERCA expression and function act as important mechanisms to sustain 'normal' relaxation to some vasodilator agents as a pathological condition is developing. Data from single cells suggest enhanced Ca 2þ extrusion, likely via PMCA may be responsible for maintenance of close to normal relaxation responses for a period of time and perhaps augmented vasodilator response at early stages of fat feeding. This study highlights the importance of examining multiple time points during disease development and the interdependence and complexity of SERCA, SOCE and PMCA function during atherosclerosis.
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